Line 38: | Line 38: | ||
<div class="column two_third_size"> | <div class="column two_third_size"> | ||
<p style="text-align: justify;">Another main limiting factor that the PHBV production is currently facing which hinders its commercialisation is the inefficient downstream processing which includes PHBV recovery from the microbial cells. PHBV is currently the only co-polymer commercially available; however, costs of production remain high and further research and development are tantamount to reaching economies of scale comparable to traditional plastics production in the industry. The high costs in manufacturing (ranging from £2 - £4 per kg) remain the limiting factor for widespread commercialization; prices closer to the £0.5 - £1.5 per kg range associated with traditional plastic production (e.g. polyethylene, polyvinylchloride, etc.) would ensure price-competitiveness of the bioplastic in the market (Choi and Lee, 1999). | <p style="text-align: justify;">Another main limiting factor that the PHBV production is currently facing which hinders its commercialisation is the inefficient downstream processing which includes PHBV recovery from the microbial cells. PHBV is currently the only co-polymer commercially available; however, costs of production remain high and further research and development are tantamount to reaching economies of scale comparable to traditional plastics production in the industry. The high costs in manufacturing (ranging from £2 - £4 per kg) remain the limiting factor for widespread commercialization; prices closer to the £0.5 - £1.5 per kg range associated with traditional plastic production (e.g. polyethylene, polyvinylchloride, etc.) would ensure price-competitiveness of the bioplastic in the market (Choi and Lee, 1999). | ||
− | This point is supported by our <a href="https://2018.igem.org/Team:Edinburgh_OG/life_cycle_assessment">Life Cycle Assessment</a> as well as our discussion with <a href="https://2018.igem.org/Team:Edinburgh_OG/Human_Practices">Cambridge | + | This point is supported by our <a href="https://2018.igem.org/Team:Edinburgh_OG/life_cycle_assessment">Life Cycle Assessment</a> as well as our discussion with <a href="https://2018.igem.org/Team:Edinburgh_OG/Human_Practices">Cambridge Consultants</a>. To address this issue, we propose an in-situ secretion system by the <em>E. coli</em> which potentially will be more environmentally friendly and time-efficient.</p> |
<h2>The phasin and hemolysin secretion system (hemolysin BD and hemolysin A)</h2> | <h2>The phasin and hemolysin secretion system (hemolysin BD and hemolysin A)</h2> | ||
<h3><strong>Overview</strong></h3> | <h3><strong>Overview</strong></h3> |
Latest revision as of 18:50, 17 October 2018